Gene · 4855
Papers3,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,624
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Notch signaling and targeted therapy in non-small cell lung cancer. | Cancer Lett | 2024 | 38301911 | PubTator, text mining | PubMed |
| A state-of-the-art review of the recent advances in exosome isolation and detection methods in viral infection. | Virol J | 2024 | 38291452 | PubTator, text mining | PubMed |
| Catalytic hydrogenation of olefins by a multifunctional molybdenum-sulfur complex. | Nat Commun | 2024 | 38280870 | PubTator, text mining | PubMed |
| Assessment of Genetic Stability in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes by Using Droplet Digital PCR. | Int J Mol Sci | 2024 | 38256178 | PubTator, text mining | PubMed |
| Identification of Molecular Markers Associated with Prostate Cancer Subtypes: An Integrative Bioinformatics Approach. | Biomolecules | 2024 | 38254687 | PubTator, text mining | PubMed |
| Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs. | Exp Hematol Oncol | 2024 | 38254219 | PubTator, text mining | PubMed |
| Effect of traditional Chinese medicine in osteosarcoma: Cross-interference of signaling pathways and potential therapeutic targets. | Medicine (Baltimore) | 2024 | 38241548 | PubTator, text mining | PubMed |
| Plasmablastic Lymphoma. A State-of-the-Art Review: Part 1-Epidemiology, Pathogenesis, Clinicopathologic Characteristics, Differential Diagnosis, Prognostic Factors, and Special Populations. | Mediterr J Hematol Infect Dis | 2024 | 38223486 | PubTator, text mining | PubMed |
| Role of TNF-α in the Pathogenesis of Migraine. | Pain Res Manag | 2024 | 38213956 | PubTator, text mining | PubMed |
| ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the JAK2/STAT3 pathway and interacting with ESM1. | J Transl Med | 2024 | 38212795 | PubTator, text mining | PubMed |
| The intricate cellular ecosystem of human peripheral veins as revealed by single-cell transcriptomic analysis. | PLoS One | 2024 | 38206912 | PubTator, text mining | PubMed |
| Exploring the Multiple Roles of Notch1 in Biological Development: An Analysis and Study Based on Phylogenetics and Transcriptomics. | Int J Mol Sci | 2024 | 38203782 | PubTator, text mining | PubMed |
| Extracellular Matrix Cues Regulate Mechanosensing and Mechanotransduction of Cancer Cells. | Cells | 2024 | 38201302 | PubTator, text mining | PubMed |
| Disparate macrophage responses are linked to infection outcome of Hantan virus in humans or rodents. | Nat Commun | 2024 | 38200007 | PubTator, text mining | PubMed |
| Role of cell rearrangement and related signaling pathways in the dynamic process of tip cell selection. | Cell Commun Signal | 2024 | 38195565 | PubTator, text mining | PubMed |
| Transcriptomic signatures of individual cell types in cerebral cavernous malformation. | Cell Commun Signal | 2024 | 38195510 | PubTator, text mining | PubMed |
| RNA-seq unravels distinct expression profiles of keloids and Dupuytren's disease. | Heliyon | 2024 | 38187218 | PubTator, text mining | PubMed |
| Integration of scRNA and bulk RNA-sequence to construct the 5-gene molecular prognostic model based on the heterogeneity of thyroid carcinoma endothelial cell. | Acta Biochim Biophys Sin (Shanghai) | 2024 | 38186223 | PubTator, text mining | PubMed |
| Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres. | J Transl Med | 2024 | 38184610 | PubTator, text mining | PubMed |
| The outcomes of different regimens depend on the molecular subtypes of pulmonary large-cell neuroendocrine carcinoma: A retrospective study in China. | Cancer Med | 2024 | 38180312 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4855/papers?page=8